Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial

397

Citations

17

References

2021

Year

Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio, Kirit M. Ardeshna, Mehdi Hamadani, Brian Hess, Brad S. Kahl, John Radford, Melhem Solh, Anastasios Stathis,

The Lancet Oncology

Loncastuximab TesirineLymphoid NeoplasiaHematological MalignancyMedicineImmunologyPathologyImmunotherapyOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1